TY  - GEN
AU  - Konstan,Michael W
AU  - Davis,Pamela B
AU  - Wagener,Jeffrey S
AU  - Hilliard,Kathleen A
AU  - Stern,Robert C
AU  - Milgram,Laura J H
AU  - Kowalczyk,Tomasz H
AU  - Hyatt,Susannah L
AU  - Fink,Tamara L
AU  - Gedeon,Christopher R
AU  - Oette,Sharon M
AU  - Payne,Jennifer M
AU  - Muhammad,Osman
AU  - Ziady,Assem G
AU  - Moen,Robert C
AU  - Cooper,Mark J
TI  - Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
SN  - 1043-0342
PY  - 2005///0421
KW  - Administration, Intranasal
KW  - C-Reactive Protein
KW  - analysis
KW  - Clinical Protocols
KW  - Complement System Proteins
KW  - Cystic Fibrosis
KW  - drug therapy
KW  - Cystic Fibrosis Transmembrane Conductance Regulator
KW  - administration & dosage
KW  - DNA
KW  - genetics
KW  - Double-Blind Method
KW  - Gene Transfer Techniques
KW  - Genetic Therapy
KW  - methods
KW  - Genetic Vectors
KW  - Interleukin-6
KW  - blood
KW  - Nanostructures
KW  - chemistry
KW  - Nasal Lavage Fluid
KW  - Nasal Mucosa
KW  - metabolism
KW  - Polymerase Chain Reaction
KW  - Time Factors
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1089/hum.2004.15.1255
ER  -